Quantitation of chromatin patterns by image analysis as a predictive tool in chemopreventive trials with vitamin A.
Nuclear textures of oral mucosal cells were quantitated by image analysis, and their suitability as markers in a chemopreventive trial explored. Subjects were chewers of tobacco-containing betel quids with well established oral leukoplakias. Treatment consisted of a weekly oral administration of vitamin A (200,000 IU/week) for six months. Leukoplakias regressed in 57.1% of the 21 trial participants. The original leukoplakias did not redevelop within four months after termination of treatment. For image analysis, biopsies were taken from leukoplakias of five chewers before administration of vitamin A, at the end of the administration, and four months after termination of treatment. Sections of paraffin-embedded biopsies were stained with the Feulgen reaction and submitted to quantitative image analysis of two parameters: variance of intensity and entropy. Both these parameters were significantly reduced in all five trial participants as a result of the six-month vitamin A treatment. During the post-treatment period, nuclei with condensed chromatin, as measured by the variance of intensity, reappeared in the mucosa of four of the five chewers examined, although no leukoplakias were detectable on visual examination of the oral cavity. The results indicate that the quantitation of nuclear textures in a small subpopulation of a chemopreventive trial could conceivably be a simple marker with a predictive value.
Stich
H F
HF
Environmental Carcinogenesis Unit, British Columbia Cancer Research Centre, Vancouver, Canada.
Palcic
B
B
Sankaranarayanan
R
R
Mathew
B
B
Nair
M K
MK
D014408:Biomarkers, Tumor / Q000032:analysis*; D002467:Cell Nucleus / Q000473:pathology; D002843:Chromatin / Q000473:pathology*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007972:Leukoplakia, Oral / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*; D009061:Mouth Mucosa / Q000473:pathology; D010865:Pilot Projects; D010947:Plants, Toxic; D012074:Remission Induction; D014030:Tobacco, Smokeless / Q000009:adverse effects; D014801:Vitamin A / Q000627:therapeutic use*
D014408:Biomarkers, Tumor; D002843:Chromatin; D014801:Vitamin A